PCA3 and prostate cancer: Due to the crucial roles of lncRNAs, recent research has explored their potential as biomarkers for cancer diagnosis [10]For instance, prostate cancer antigen 3 (PCA3) in urine samples has been approved by the US Food and Drug Administration as a biomarker for prostate cancer [11].